Skip to main content

and
  1. No Access

    Article

    Does supplemental private health insurance incentivize household risky financial asset investment? Evidence from the China Household Financial Survey

    Private health insurance (PHI) is considered a supplement to public medical insurance schemes in China. To the extent that PHI coverage may offset background risk by decreasing medical expenditure risk, it may...

    Si Shi, Yawen Jiang in International Journal of Health Economics and Management (2022)

  2. Article

    Open Access

    Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life

    Cost-effective threshold (CET) is essential for health technology assessment and decision-making based on health economic evaluations. Recently, it has been argued that the commonly used once and three times o...

    Dan Cai, Si Shi, Shan Jiang, Lei Si, **g Wu in The European Journal of Health Economics (2022)

  3. Article

    Open Access

    Quality of life and cost consequence of delays in endovascular treatment for acute ischemic stroke in China

    Although endovascular therapy (EVT) improves clinical outcomes in patients with acute ischemic stroke, the time of EVT initiation significantly influences clinical outcomes and healthcare costs. This study eva...

    Weiyi Ni, Wolfgang G. Kunz, Mayank Goyal, Li** Chen in Health Economics Review (2022)

  4. Article

    Open Access

    Risk selection into supplemental private health insurance in China

    Information on risk selection is important for the regulation and development of supplemental private health insurance (PHI). The research on risk selection into supplemental PHI has been documented in several...

    Yawen Jiang, Weiyi Ni in Health Economics Review (2019)